65.65
전일 마감가:
$67.16
열려 있는:
$68
하루 거래량:
2.33M
Relative Volume:
1.30
시가총액:
$3.49B
수익:
-
순이익/손실:
$-38.99M
주가수익비율:
-21.91
EPS:
-2.9966
순현금흐름:
$-24.94M
1주 성능:
-2.76%
1개월 성능:
+10.88%
6개월 성능:
-12.73%
1년 성능:
+17.53%
Soleno Therapeutics Inc Stock (SLNO) Company Profile
명칭
Soleno Therapeutics Inc
전화
650-213-8444
주소
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
SLNO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
SLNO
Soleno Therapeutics Inc
|
65.65 | 3.57B | 0 | -38.99M | -24.94M | -2.9966 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-07 | 개시 | Goldman | Buy |
| 2025-08-20 | 개시 | Wells Fargo | Overweight |
| 2025-06-23 | 개시 | TD Cowen | Buy |
| 2025-03-05 | 재개 | Stifel | Buy |
| 2024-12-02 | 재확인 | Robert W. Baird | Outperform |
| 2024-12-02 | 재확인 | Stifel | Buy |
| 2024-09-03 | 개시 | H.C. Wainwright | Buy |
| 2024-05-10 | 개시 | Robert W. Baird | Outperform |
| 2024-02-05 | 개시 | Piper Sandler | Overweight |
| 2024-01-23 | 개시 | Stifel | Buy |
| 2023-11-21 | 재개 | Guggenheim | Buy |
| 2020-09-29 | 개시 | Guggenheim | Buy |
| 2020-01-10 | 개시 | Craig Hallum | Buy |
| 2019-12-23 | 개시 | Oppenheimer | Outperform |
| 2018-02-13 | 재확인 | Maxim Group | Buy |
모두보기
Soleno Therapeutics Inc 주식(SLNO)의 최신 뉴스
Hot Picks: Investor highlights small-cap opportunities in energy, industrial tech and biotech - BNN Bloomberg
Has Soleno Therapeutics Inc. formed a bullish divergence2025 Top Decliners & Reliable Entry Point Alerts - newser.com
Published on: 2025-11-03 08:08:49 - newser.com
Is Soleno Therapeutics Inc. (6XC) stock good for long term investingLong Setup & Entry Point Confirmation Signals - newser.com
Can Soleno Therapeutics Inc. stock outperform in 2025 bull market2025 Earnings Surprises & Safe Entry Momentum Tips - newser.com
Soleno Therapeutics Inc (SLNO) Q3 2025 Earnings Report Preview: What To Look For - GuruFocus
Will Soleno Therapeutics Inc. stock reach Wall Street targetsTrade Risk Assessment & Consistent Income Trade Recommendations - newser.com
Full technical analysis of Soleno Therapeutics Inc. stockWeekly Trade Summary & AI Optimized Trading Strategy Guides - newser.com
Will Soleno Therapeutics Inc. outperform the marketJuly 2025 News Drivers & Expert-Curated Trade Recommendations - newser.com
How moving averages guide Soleno Therapeutics Inc. tradingAnalyst Downgrade & Long-Term Safe Investment Plans - newser.com
Will Soleno Therapeutics Inc. (6XC) stock outperform small cap peersPortfolio Gains Report & Comprehensive Market Scan Reports - newser.com
Order flow analysis tools used on Soleno Therapeutics Inc.2025 Earnings Surprises & Entry Point Strategy Guides - newser.com
What hedge fund activity signals for Soleno Therapeutics Inc. stock2025 Trade Ideas & Real-Time Volume Analysis Alerts - newser.com
Moody Aldrich Partners LLC Has $3.48 Million Position in Soleno Therapeutics, Inc. $SLNO - MarketBeat
How Soleno Therapeutics Inc. stock benefits from strong dollarJuly 2025 Intraday Action & AI Forecasted Entry/Exit Points - newser.com
Soleno Therapeutics, Inc. $SLNO Shares Acquired by Emerald Mutual Fund Advisers Trust - MarketBeat
Is Soleno Therapeutics Inc. a candidate for recovery play2025 Market Sentiment & Consistent Growth Equity Picks - newser.com
Is Soleno Therapeutics Inc. stock a bargain at current levelsEarnings Overview Summary & Real-Time Chart Pattern Alerts - newser.com
Will Soleno Therapeutics Inc. stock benefit from upcoming earnings reportsMarket Risk Summary & Daily Market Momentum Tracking - newser.com
Soleno Therapeutics (SLNO): Assessing Valuation Following Securities Probe and Short-Seller Safety Allegations - Sahm
Strategies to average down on Soleno Therapeutics Inc.July 2025 Closing Moves & Consistent Income Trade Ideas - newser.com
Will Soleno Therapeutics Inc. stock outperform tech sector in 2025Portfolio Return Report & Safe Entry Zone Identification - newser.com
Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – SLNO - Bluefield Daily Telegraph
Soleno Therapeutics (SLNO) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Soleno Therapeutics, Inc. $SLNO is Emerald Advisers LLC's 6th Largest Position - MarketBeat
Soleno Therapeutics Stock Jumped 5.2% in a Day, What Now? - Trefis
What analysts say about Soleno Therapeutics Inc stockGap Up/Gap Down Analysis & Never Miss the Next Wealth Opportunity - earlytimes.in
Soleno Therapeutics to Participate in Upcoming November Conferences - The Manila Times
Soleno Therapeutics (NASDAQ: SLNO) sets November talks at Guggenheim and Jefferies - Stock Titan
Soleno Therapeutics Inc (SLNO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):